Small Cap Gainers: MTOR, OCGN, AMLX
3:38 pm Tuesday, February 22nd, 2022
Meritor Inc (NYSE:MTOR): Agreed to be acquired by Cummins (CMI) for $36.50/share in cash, representing a total transaction value of approx. $3.7 bln, including debt and net of acquired cash, to provide Cummins with the ability to provide integrated powertrain solutions across combustion and electric power applications amid accelerating demand for decarbonized solutions.
Ocugen Inc (NASDAQ:OCGN) announced that the FDA lifted its clinical hold on co’s investigational new drug application to evaluate COVID-19 vaccine candidate BBV152, also known as COVAXIN. Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company’s pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis.
Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) continued strength brings the stock to new record highs. The stock has gained approx. +46% over the past week. Amylyx Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases in the United States and Canada.
